Search research articles
Contact Us
Filters
Showing results (111-120 of 139) with videos related to
Page
of 14
Sort By:
Transplantation Proceedings
|
June 1, 1988
Bone marrow transplantation in metabolic diseases
S O Lie, A Glomstein, S H Slørdahl, et al.
Lancet (London, England)
|
July 20, 1985
Aluminium overload, a predisposing condition for epileptic seizures in renal-transplant patients treated with cyclosporin?
K P Nordal, T Talseth, E Dahl, et al.
Bone Marrow Transplantation
|
July 15, 2003
Fewer relapses and increased chronic GVHD in patients transplanted with blood stem cells: a 5-year follow-up in a single centre study
D Heldal, L Brinch, G Tjønnfjord, et al.
Transplantation Proceedings
|
October 1, 1987
Improved renal graft function in triple-drug treatment with low-dose cyclosporine
H Persson, C Andersson, C Lundgren, et al.
Transplantation Proceedings
|
February 1, 1991
BMA 031 effectively reverses steroid-resistant rejection in renal transplants
P F Pfeffer, A Jakobsen, D Albrechtsen, et al.
Transplantation Proceedings
|
February 1, 1990
Cardiac transplantation from a blood group ABO-incompatible donor: a case report
D Albrechtsen, O Geiran, A Foerster, et al.
Transplantation Proceedings
|
February 1, 1990
Renal replacement therapy in the cyclosporine era: results of a national transplantation program
D Albrechtsen, K J Berg, I Brekke, et al.
Transplantation Proceedings
|
February 1, 1989
Recipient age--an important factor for the outcome of cadaver renal transplantation in patients treated with cyclosporine
G Lundgren, H Persson, D Albrechtsen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 1, 1977
HLA-D associated alloantisera react with molecules similar to Ia antigens
M J Giphart, J F Kaufman, A Fuks, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|
January 30, 1991
[Allogeneic bone marrow transplantation in adults. Results after fractionated whole body irradiation and high dosage cyclophosphamide and use of HLA-compatible sibling donors]
L Brinch, S A Evensen, D Albrechtsen, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 139) with videos related to
Sort By:
Page
of 14
Transplantation Proceedings
|
June 1, 1988
Bone marrow transplantation in metabolic diseases
S O Lie, A Glomstein, S H Slørdahl, et al.
Lancet (London, England)
|
July 20, 1985
Aluminium overload, a predisposing condition for epileptic seizures in renal-transplant patients treated with cyclosporin?
K P Nordal, T Talseth, E Dahl, et al.
Bone Marrow Transplantation
|
July 15, 2003
Fewer relapses and increased chronic GVHD in patients transplanted with blood stem cells: a 5-year follow-up in a single centre study
D Heldal, L Brinch, G Tjønnfjord, et al.
Transplantation Proceedings
|
October 1, 1987
Improved renal graft function in triple-drug treatment with low-dose cyclosporine
H Persson, C Andersson, C Lundgren, et al.
Transplantation Proceedings
|
February 1, 1991
BMA 031 effectively reverses steroid-resistant rejection in renal transplants
P F Pfeffer, A Jakobsen, D Albrechtsen, et al.
Transplantation Proceedings
|
February 1, 1990
Cardiac transplantation from a blood group ABO-incompatible donor: a case report
D Albrechtsen, O Geiran, A Foerster, et al.
Transplantation Proceedings
|
February 1, 1990
Renal replacement therapy in the cyclosporine era: results of a national transplantation program
D Albrechtsen, K J Berg, I Brekke, et al.
Transplantation Proceedings
|
February 1, 1989
Recipient age--an important factor for the outcome of cadaver renal transplantation in patients treated with cyclosporine
G Lundgren, H Persson, D Albrechtsen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 1, 1977
HLA-D associated alloantisera react with molecules similar to Ia antigens
M J Giphart, J F Kaufman, A Fuks, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|
January 30, 1991
[Allogeneic bone marrow transplantation in adults. Results after fractionated whole body irradiation and high dosage cyclophosphamide and use of HLA-compatible sibling donors]
L Brinch, S A Evensen, D Albrechtsen, et al.
Page
of 14